![]() |
市场调查报告书
商品编码
1913342
异丙醇市场机会、成长要素、产业趋势分析及2026年至2035年预测Isopropyl Alcohol Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
全球异丙醇市场预计到 2025 年将达到 73 亿美元,到 2035 年将达到 137 亿美元,年复合成长率为 6.4%。

全球卫生标准的日益重视、药品产能的不断扩大以及技术主导行业对精密级清洁解决方案的日益增长的需求,共同支撑了市场成长。异丙醇因其消毒能力和作为药品生产中可靠溶剂的作用而备受青睐。长期以来,人们对卫生和感染预防意识的不断提高,使得市场需求远超以往的激增,巩固了其在多个行业中作为关键化学品的地位。同时,监管压力和环境优先事项正在加速向生物基生产途径和更环保的溶剂体系转型。对永续化学品製造和供应链优化的投资正在重塑生产模式,使供应商能够在提升环境绩效的同时,专注于特种和高纯度应用。这些结构性发展将持续增强市场的韧性和长期成长潜力。
| 市场覆盖范围 | |
|---|---|
| 开始年份 | 2025 |
| 预测年份 | 2026-2035 |
| 起始值 | 73亿美元 |
| 预测金额 | 137亿美元 |
| 复合年增长率 | 6.4% |
2025年,工业级异丙醇市占率达到46.9%,预计到2035年将以6.4%的复合年增长率成长。其市场主导地位主要得益于其成本效益和广泛的功能应用。较低的提纯要求降低了生产能耗,并使其价格更具竞争力,从而支持工业运作中的大规模应用。
预计到 2025 年,医疗和製药领域将占市场份额的 34.1%,并预计从 2026 年到 2035 年以 6.5% 的复合年增长率增长。消毒剂在消毒和灭菌应用中的重要作用以及作为药用级溶剂的应用,正在推动强劲的需求。
到 2025 年,北美异丙醇市占率将达到 24.3%。该地区的成长得益于医疗保健、化学品製造和专业清洁行业的消费量增加,以及强大的工业基础设施和一致的法规结构的支持。
The Global Isopropyl Alcohol Market was valued at USD 7.3 billion in 2025 and is estimated to grow at a CAGR of 6.4% to reach USD 13.7 billion by 2035.

Market growth is supported by rising global emphasis on hygiene standards, expanding pharmaceutical production capacity, and increasing use of precision-grade cleaning solutions across technology-driven industries. Isopropyl alcohol remains widely valued for its disinfecting capability and its role as a reliable solvent in pharmaceutical manufacturing. Heightened long-term awareness around sanitation and infection prevention has sustained demand well beyond earlier surges, reinforcing its position as an essential chemical across multiple industries. In parallel, regulatory pressure and environmental priorities are accelerating the shift toward bio-based production pathways and greener solvent systems. Investments in sustainable chemical manufacturing and supply chain optimization are reshaping production models, enabling suppliers to target specialty and high-purity applications while improving environmental performance. These structural developments continue to enhance market resilience and long-term growth potential.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $7.3 Billion |
| Forecast Value | $13.7 Billion |
| CAGR | 6.4% |
The industrial-grade isopropyl alcohol segment held 46.9% share in 2025 and is expected to grow at a CAGR of 6.4% through 2035. Its dominance is driven by cost efficiency and broad functional applicability. Lower purification requirements reduce production energy intensity, allowing competitive pricing and supporting large-scale usage across industrial operations.
The healthcare and pharmaceutical segment held 34.1% share in 2025 and is forecast to expand at a CAGR of 6.5% from 2026 to 2035. Strong demand is supported by the critical role of isopropyl alcohol in sanitation, antiseptic use, and pharmaceutical-grade solvent applications.
North America Isopropyl Alcohol Market represented 24.3% share in 2025. Regional growth is driven by rising consumption across healthcare, chemical manufacturing, and professional cleaning sectors, supported by strong industrial infrastructure and consistent regulatory frameworks.
Key companies operating in the Global Isopropyl Alcohol Market include Dow, LyondellBasell, SABIC, Shell Chemicals, LG Chem, Mitsubishi Chemical Group, ExxonMobil, INEOS, Solvay, Sasol, PetroChina, Mitsui Chemicals, Deepak Fertilisers and Petrochemicals Corporation Ltd., Tokuyama Corporation, ISU Chemical, SK Geo Centric, LCY, Kukdo Chemical, Jiangsu Denoir Specialty Chemicals, and Shandong Dadi Supu Chemical Co., Ltd.
Companies in the isopropyl alcohol market are strengthening their competitive position through capacity expansion, sustainability-focused innovation, and portfolio optimization. Many producers are investing in bio-based and low-emission production technologies to meet regulatory and customer expectations. Strategic geographic expansion and localized manufacturing are helping reduce supply risks and improve responsiveness. Firms are also emphasizing high-purity and specialty-grade offerings to capture value-added segments. Long-term supply agreements with pharmaceutical and industrial customers are being used to stabilize demand, while operational efficiency initiatives and digitalized production systems support cost competitiveness and consistent product quality.